Lavipharm S.A. Share Price

Equities

LAVI

GRS246003008

Pharmaceuticals

Delayed Athens S.E. 05:13:43 29/04/2024 pm IST 5-day change 1st Jan Change
0.852 EUR -0.93% Intraday chart for Lavipharm S.A. +0.59% +7.04%

Financials

Sales 2022 46.01M 49.32M 4.11B Sales 2023 50.93M 54.6M 4.55B Capitalization 134M 143M 11.95B
Net income 2022 - 0 0 Net income 2023 1M 1.07M 89.39M EV / Sales 2022 1.81 x
Net Debt 2022 18.93M 20.29M 1.69B Net Debt 2023 24.04M 25.77M 2.15B EV / Sales 2023 3.1 x
P/E ratio 2022
9.91 x
P/E ratio 2023
71.4 x
Employees 307
Yield 2022 *
-
Yield 2023
-
Free-Float 38.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.93%
1 week+0.59%
Current month-3.84%
1 month+0.24%
3 months-5.33%
6 months+35.67%
Current year+7.04%
More quotes
1 week
0.83
Extreme 0.83
0.88
1 month
0.78
Extreme 0.78
0.90
Current year
0.76
Extreme 0.76
0.96
1 year
0.39
Extreme 0.39
0.96
3 years
0.35
Extreme 0.346
2.22
5 years
0.35
Extreme 0.346
2.22
10 years
0.16
Extreme 0.162
2.22
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 01/21/01
Compliance Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 84 01/09/01
Director/Board Member - 01/03/01
More insiders
Date Price Change Volume
29/24/29 0.852 -0.93% 17 122
26/24/26 0.86 +3.61% 90,175
25/24/25 0.83 -1.89% 91,288
24/24/24 0.846 -1.05% 125,020
23/24/23 0.855 +0.94% 123,376

Delayed Quote Athens S.E., April 29, 2024 at 05:13 pm IST

More quotes
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. It is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.
More about the company